Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ADXN

Addex Therapeutics (ADXN)

Addex Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADXN
DateTimeSourceHeadlineSymbolCompany
01/08/202512:00AMGlobeNewswire Inc.Addex to Present at the 2025 Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
11/22/20245:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
11/22/202412:00AMGlobeNewswire Inc.Addex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/11/202412:00AMGlobeNewswire Inc.Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024NASDAQ:ADXNAddex Therapeutics Ltd
09/30/20245:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
09/30/202412:00AMGlobeNewswire Inc.Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
09/19/20245:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
09/19/202412:00AMGlobeNewswire Inc.Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitNASDAQ:ADXNAddex Therapeutics Ltd
09/04/202412:00AMGlobeNewswire Inc.Addex to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
08/27/20245:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
08/27/202412:00AMGlobeNewswire Inc.Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationNASDAQ:ADXNAddex Therapeutics Ltd
08/14/20247:12PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
08/05/20248:00PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
07/22/20245:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
07/22/202412:00AMGlobeNewswire Inc.Addex’s Partner Discontinues ADX71149 development in EpilepsyNASDAQ:ADXNAddex Therapeutics Ltd
07/15/20245:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
07/15/202412:00AMGlobeNewswire Inc.Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)NASDAQ:ADXNAddex Therapeutics Ltd
07/12/202412:00AMGlobeNewswire Inc.Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)NASDAQ:ADXNAddex Therapeutics Ltd
07/01/202412:00AMGlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Annual General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
06/06/20246:29AMIH Market NewsUS Index Futures Mixed; Oil Prices RiseNASDAQ:ADXNAddex Therapeutics Ltd
06/06/20245:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
06/06/202412:00AMGlobeNewswire Inc.Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
06/05/20245:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
06/05/202412:00AMGlobeNewswire Inc.Addex Convenes Annual General Meeting 2024NASDAQ:ADXNAddex Therapeutics Ltd
05/31/202412:00AMGlobeNewswire Inc.Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024NASDAQ:ADXNAddex Therapeutics Ltd
05/08/202412:00AMGlobeNewswire Inc.Addex to Present at Bio€quity Europe 2024NASDAQ:ADXNAddex Therapeutics Ltd
04/29/202412:00AMGlobeNewswire Inc.Addex Provides Update on ADX71149 Phase 2 Epilepsy StudyNASDAQ:ADXNAddex Therapeutics Ltd
04/19/202412:00AMGlobeNewswire Inc.Addex to Present at the Swiss Biotech Day 2024NASDAQ:ADXNAddex Therapeutics Ltd
04/18/202412:00AMGlobeNewswire Inc.Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
04/11/202412:00AMGlobeNewswire Inc.Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024NASDAQ:ADXNAddex Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ADXN